Abiopharma

News list

📋 BUCHI J KEVIN (Director) plans to sell 169K shares of Amneal Pharmaceuticals, Inc. (at $17.31 each, total $2.9M) Filed: Aug 11, 2026 | ID: 000494

Full text

News bot Aug. 11, 2026, 4:33 p.m.
📋 Form 144 Filing: BUCHI J KEVIN

Company: Amneal Pharmaceuticals, Inc.

Filing Date: 2026-08-11

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 168,573
- Price per Share: $17.31
- Total Value: $2,917,998.00
- Planned Sale Date: 2026-08-11
- Broker: Charles Schwab Corp
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-38485
- Issuer Contact Phone: (908) 947-3120
- Issuer Address: 400 CROSSING BLVD, BRIDGEWATER, NJ, 08807
- Broker Address: 3000 Schwab Way, Westlake, TX, 76262
- Shares Outstanding: 319353919.0
- Number of Securities to be Sold: 6
- Remarks: Account Title: Memorandum of Trust of J. Kevin Buchi U/A DTD 11/04/2021 J. Kevin Buchi as trustee
- Signature: J. Kevin Buchi